八旬患者经颈动脉血运重建与内膜剥脱及经股动脉支架的比较
本研究基于血管质量倡议(VQI)数据库,纳入2016年9月至2019年12月接受颈动脉内膜剥脱术(CEA)、经股动脉颈动脉支架(TFCAS)或经颈动脉血运重建(TCAR)的33115例颈动脉狭窄患者。在八旬患者中,TCAR与CEA的30天和1年卒中/死亡风险相似,而TFCAS风险显著高于CEA。TCAR可作为高龄高手术风险患者的一种微创选择。
要点
- 八旬患者中,TCAR与CEA的30天卒中/死亡风险相似(HR 1.12,95%CI 0.59-2.13)。
- 八旬患者中,TFCAS的30天卒中/死亡风险显著高于CEA(HR 1.78,95%CI 1.10-2.89)。
- TCAR可能作为高龄、高解剖/手术/临床风险CEA患者的微创治疗选择。
核心结论
- 在八旬颈动脉狭窄患者中,TCAR与CEA的30天和1年卒中/死亡风险相似。
- TFCAS在八旬患者中30天和1年卒中/死亡风险均显著高于CEA。
- TCAR可能作为高龄、高解剖/手术/临床风险CEA患者的微创治疗选择。
研究设计与样本
- 回顾性队列研究,使用血管质量倡议(VQI)数据库,纳入2016年9月至2019年12月接受CEA、TFCAS或TCAR的颈动脉狭窄患者,共33115例。
- 患者按年龄分为60-69岁、70-79岁和80-90岁组,比较30天和1年卒中/死亡复合终点。
- 采用Cox比例风险模型调整人口学、临床因素、症状、医院CEA手术量和聚类效应。
主要发现
- 总体30天卒中/死亡率为1.5%,1年卒中/死亡率为4.4%。
- 八旬患者30天和1年卒中/死亡率分别为2.3%和6.3%,为各年龄组最高。
- 在所有患者中,TCAR与CEA的30天卒中/死亡风险相似(HR 1.10,95%CI 0.75-1.62),1年风险略高(HR 1.34,95%CI 1.02-1.76)。
- 在八旬患者中,TCAR与CEA的30天卒中/死亡风险相似(HR 1.12,95%CI 0.59-2.13),1年风险亦相似(HR 1.28,95%CI 0.85-1.94)。
- 在八旬患者中,TFCAS与CEA相比,30天卒中/死亡风险更高(HR 1.78,95%CI 1.10-2.89),1年风险也更高(HR 1.85,95%CI 1.35-2.54)。
临床怎么用
- 对于八旬颈动脉狭窄患者,TCAR可作为CEA的替代选择,尤其适用于高解剖、手术或临床风险患者。
- 在八旬患者中应避免优先选择TFCAS,因其卒中/死亡风险显著高于CEA。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Transfemoral carotid artery stenting (TFCAS) has higher combined stroke and death rates in elderly patients with carotid artery stenosis compared with carotid endarterectomy (CEA). However, transcarotid artery revascularization (TCAR) may have similar outcomes to CEA. This study compared outcomes after TCARs relative to those after CEAs and TFCAS, focusing on elderly patients. METHODS: We included all patients with carotid artery stenosis and no prior endarterectomy or stenting who underwent either a CEA, TFCAS, or TCAR in the Vascular Quality Initiative from September 2016 (TCAR commercially available) to December 2019. We categorized patients into age decades: 60 to 69 years, 70 to 79 years, and 80 to 90 years. Outcomes included 30-day and 1-year composite rates of stroke or death. Cox proportional hazards models evaluated both outcomes after adjusting for patient demographics, clinical factors, symptomatology, hospital CEA volume, and clustering. RESULTS: We identified 33,115 patients who underwent either a CEA, TFCAS, or TCAR for carotid artery stenosis (35% in their 60s, 44% in their 70s, and 21% in their 80s), where one-half (50%) were symptomatic. The majority of patients had CEAs (80%), followed by TFCAS (11%) and TCARs (9.1%). The overall rate of 30-day stroke/death was 1.5% and of 1-year stroke/death was 4.4%. Octogenarians had the highest 30-day and 1-year stroke/death rates relative to their peers (2.3% and 6.3%, respectively). Among all patients, the adjusted hazards of TCARs relative to CEAs was similar for 30-day stroke/death (hazard ratio [HR] 1.10; 95% confidence interval [CI], 0.75-1.62) and slightly higher for 1-year stroke/death (HR, 1.34; 95% CI, 1.02-1.76). Among octogenarians, however, the adjusted hazards of TCARs relative to CEAs was similar for both 30-day stroke/death (HR, 1.12; 95% CI, 0.59-2.13) and 1-year stroke/death (HR, 1.28; 95% CI, 0.85-1.94). TFCAS relative to CEAs had higher hazards of both 30-day stroke/death (HR, 1.78; 95% CI, 1.10-2.89) and 1-year stroke/death (HR, 1.85; 95% CI, 1.35-2.54) in octogenarians. CONCLUSIONS: TCARs had similar outcomes relative to CEAs among octogenarians with respect to 30-day and 1-year rates of stroke/death. TCAR may serve as a promising less invasive treatment for carotid disease in older patients who are deemed high anatomic, surgical, or clinical risk for CEAs.
引用
- Mehta A, Patel PB, Bajakian D, et al. Transcarotid artery revascularization versus carotid endarterectomy and transfemoral stenting in octogenarians. J Vasc Surg. 2021. PMID: 34082003. doi:10.1016/j.jvs.2021.05.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。